NPL.SI Niks Professional (SES) after hours volume spike S$0.23 09 Mar 2026: 41.55% model upside

We saw a clear volume spike in NPL.SI stock in after hours trading on 09 Mar 2026. The stock closed at S$0.23 on the Singapore Exchange (SES) with 170,000 shares traded, versus an average daily volume of 3,200. That gives a relative volume of 53.13x, a signal that institutional or block activity likely drove the move. For traders using a volume spike strategy, this change increases short-term liquidity and reopens interest in Niks Professional Ltd (NPL.SI) as a small-cap healthcare play in SGD.

Trade details and volume spike in NPL.SI stock

Niks Professional Ltd (NPL.SI) recorded 170,000 shares traded in after hours, far above the 3,200 average. Price held at S$0.23, matching the session high and previous close. The volume jump produced a relative volume of 53.13x, which often precedes directional continuation or a reversal once normal session liquidity returns. We view this as an actionable liquidity event for short-term traders and scanners monitoring volume spikes.

Valuation and financial snapshot for NPL.SI stock

At S$0.23, market cap stands near S$29,900,000 with 130,000,000 shares outstanding. Reported EPS is S$0.01 and the quoted PE is 23.00. Key ratios show price to book near 1.53 and current ratio 5.31, reflecting a conservative balance sheet. Trailing metrics include free cash flow yield about 7.66% and operating margin around 17.60%, which supports a valuation case if growth steadies.

Technicals, liquidity and trading setup for NPL.SI stock

Short-term momentum is mixed: RSI at 48.15 suggests neutral momentum. Price sits above the 50-day average of S$0.2254 and the 200-day average of S$0.20292, showing modest technical support. On the volume spike, order book depth will matter; higher after-hours activity should improve liquidity at normal session open. Traders should watch for volume persistence and whether price breaks above the recent S$0.23 high on higher-than-average intraday volume.

Meyka AI grades and model forecast for NPL.SI stock

Meyka AI rates NPL.SI with a score of 67.11 out of 100 — Grade B, suggestion HOLD. This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly target of S$0.32556, implying 41.55% upside from the current S$0.23. Forecasts are model-based projections and not guarantees.

Risks, sector context and catalysts for NPL.SI stock

Niks operates in Healthcare – Medical Specialties within Singapore. Sector peers have average P/E near 21.09 and stronger scale. Key risks include patchy revenue growth, dividend cuts, and low free-float liquidity. Catalysts include new clinic rollouts, product retail expansion, and improved same-store sales. Watch company announcements and regulatory updates closely; earnings or operational news around clinic performance can move the small-cap stock rapidly.

Price targets, analyst view and trading strategy for NPL.SI stock

Given current metrics and the model output, conservative near-term price targets are S$0.25 (short-term resistance) and S$0.3256 (12-month model target). That equates to 8.70% and 41.55% implied upside respectively. For a volume-spike strategy, consider staged entries with tight risk controls and watch average volume normalisation. Use stop loss below S$0.20 if market structure weakens.

Final Thoughts

The after-hours volume spike in NPL.SI stock on 09 Mar 2026 highlights renewed market attention for Niks Professional Ltd on the Singapore Exchange (SES). Trade flow showed 170,000 shares versus a 3,200 average, a clear liquidity event. Fundamentals show a modest PE of 23.00, EPS S$0.01, and healthy cash metrics including a current ratio of 5.31. Meyka AI’s grade (score 67.11/100, Grade B, HOLD) balances solid cash flows against small-cap and liquidity risks. Our forecast model projects S$0.32556 in 12 months, implying 41.55% upside from S$0.23. This projection is model-based and not a guarantee. Short-term traders should watch whether volume sustains into regular sessions and confirm price action above S$0.23 before adding exposure. Long-term investors should weigh clinic expansion prospects against healthcare sector comparables and liquidity constraints. For live updates and order book reads, see the company site and SGX announcements and use Meyka AI’s real-time tools to track volume persistence and news flow company website SGX announcements and our internal stock page Meyka NPL.SI.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.